AAAAAA
Results:
1-15
|
Results: 15
Authors:
Nicholson, CD
Lensing, AWA
Citation: Cd. Nicholson et Awa. Lensing, Old antithrombotics: ready to retire?, EXPERT OP I, 10(5), 2001, pp. 785-788
Authors:
Davidson, BL
Lensing, AWA
Citation: Bl. Davidson et Awa. Lensing, Should echocardiography of the right ventricle help determine who receivesthrombolysis for pulmonary embolism?, CHEST, 120(1), 2001, pp. 6-8
Authors:
Simioni, P
Prandoni, P
Lensing, AWA
Manfrin, D
Tormene, D
Gavasso, S
Girolami, B
Sardella, C
Prins, M
Girolami, A
Citation: P. Simioni et al., Risk for subsequent venous thromboembolic complications in carriers of theprothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis, BLOOD, 96(10), 2000, pp. 3329-3333
Authors:
Davidson, BL
Lensing, AWA
Citation: Bl. Davidson et Awa. Lensing, Prolonged prophylaxis after joint replacement: Another step sideways?, ANN INT MED, 132(11), 2000, pp. 914-915
Authors:
Hutten, BA
Lensing, AWA
Kraaijenhagen, RA
Prins, MH
Citation: Ba. Hutten et al., Safety of treatment with oral anticoagulants in the elderly - A systematicreview, DRUG AGING, 14(4), 1999, pp. 303-312
Authors:
Lensing, AWA
Citation: Awa. Lensing, Anticoagulation in acute ischaemic stroke: deep vein thrombosis preventionand long-term stroke outcomes, BL COAG FIB, 10, 1999, pp. S123-S127
Authors:
Lensing, AWA
Prins, MH
Citation: Awa. Lensing et Mh. Prins, Recurrent deep vein thrombosis and two coagulation factor gene mutations: Quo vadis?, THROMB HAEM, 82(6), 1999, pp. 1564-1566
Authors:
Prandoni, P
Lensing, AWA
Prins, MH
Bagatella, P
Scudeller, A
Girolami, A
Citation: P. Prandoni et al., Which is the outcome of the post-thrombotic syndrome?, THROMB HAEM, 82(4), 1999, pp. 1358-1358
Authors:
Prandoni, P
Lensing, AWA
Prins, MH
Bagatella, P
Scudeller, A
Girolami, A
Citation: P. Prandoni et al., Which is the outcome of the post-thrombotic syndrome?, THROMB HAEM, 82(3), 1999, pp. 1196-1197
Authors:
Prandoni, P
Lensing, AWA
Bagatella, P
Simioni, P
Girolami, A
Citation: P. Prandoni et al., Low rate of warfarin-related major bleeding in patients with recurrent venous thromboembolism, THROMB HAEM, 82(1), 1999, pp. 158-159
Authors:
Sanson, BJ
Lensing, AWA
Prins, MH
Ginsberg, JS
Barkagan, ZS
Lavenne-Pardonge, E
Brenner, B
Dulitzky, M
Nielsen, JD
Boda, Z
Turi, S
MacGillavry, MR
Hamulyak, K
Theunissen, IM
Hunt, BJ
Buller, HR
Citation: Bj. Sanson et al., Safety of low-molecular-weight heparin in pregnancy: A systematic review, THROMB HAEM, 81(5), 1999, pp. 668-672
Authors:
Planes, A
Samama, MM
Lensing, AWA
Buller, HR
Barre, J
Vochelle, N
Beau, B
Citation: A. Planes et al., Prevention of deep vein thrombosis after hip replacement - Comparison between two low-molecular-weight heparins, tinzaparin and enoxaparin, THROMB HAEM, 81(1), 1999, pp. 22-25
Authors:
Lensing, AWA
Prandoni, P
Prins, MH
Buller, HR
Citation: Awa. Lensing et al., Deep-vein thrombosis, LANCET, 353(9151), 1999, pp. 479-485
Authors:
Kraaijenhagen, RA
Lensing, AWA
Wallis, JW
van Beek, EJR
ten Cate, JW
Buller, HR
Citation: Ra. Kraaijenhagen et al., Diagnostic management of venous thromboembolism, BAIL CLIN H, 11(3), 1998, pp. 541-586
Authors:
Lensing, AWA
Citation: Awa. Lensing, Surrogate endpoints for the assessment of efficacy in venous thromboembolism treatment trials, HAEMOSTASIS, 28, 1998, pp. 127-130
Risultati:
1-15
|